Bill Detail
H.R. 10227
Congress: 119
Title
INSULIN Act of 2026
Summary
No summary is available in Pulse’s cached record. Check Congress.gov for the official summary.
Sponsor
Rep. Diana DeGette [D-CO-1]
Status
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Status as of Nov 13, 2026, 4:59 PM · synced 1d ago
Introduced
2026-09-02
Data source mode: congress-gov
Bill Engagement
INSULIN Act of 2026
Lobbyists on the case
These are cached disclosure mentions, not verified current representation or confirmed event attendance.
- American Diabetes Association1 filing · 2 lobs
- Gwen Rathbun2026 Q3
- Jennifer Sherman2026 Q3
Limited preview · paid intelligence
Keep the intelligence current—not just this one record.
Unlock every organization and lobbyist filing on this bill, the complete event and issue map, private team positions, and recurring movement alerts across the portfolio.
Federal Intelligence is $2,500 one-time for three months, or $9,000 for twelve months prepaid, for one named user. Full tracked federal calendar, connected organization/bill/disclosure research, and a private workspace. Fixed terms; no automatic renewal. No demo or scope email is required for standard access.
After verified successful payment, access is activated within one business day and a secure setup link is emailed. Your term starts at activation. These links do not charge you or unlock records. A free alert subscription does not grant full access.